BILLS-117hr3437ih.pdf

2021 later than 180 days MAY 20, 2021 each of fiscal years 2022 2023 later than 2 years fiscal 1ST SESSION H. R. 3437 4 years one year annually

the ‘‘Long

PO 00000 Frm 00003 Fmt PO 00000 Frm 00011 Fmt PO 00000 Frm 00009 PO 00000 Frm 00005 PO 00000 Frm 00006 PO 00000 Frm 00010 PO 00000 Frm 00002 PO 00000 Frm 00008 Fmt PO 00000 Frm 00007 PO 00000 Frm 00004 PO 00000 Frm 00001

the United States Georgia BioBond Treas- California Mississippi Illinois the United States of America

BioBond

Biobonds

DSK79L0C42PROD Treasury SEC Health and Human Services BioBonds Human Services Congress Federal Health Food, Drug Drug Administration FISCAL AGENTS the BioBond Program Federal Food, Drug THE HOUSE OF REPRESENTATIVES the Biobonds Program the Committee on Energy and Commerce Senate the Federal Credit Reform Act Advancing New Studies for Biomedical Research the Food and Drug Administration the Comptroller General GAO STUDY BIOBOND the Department of the Treasury U.S.C. APPROPRIATIONS the Federal Food House of Representa- BioBonds Program

SEWELL RUSH FITZPATRICK COHEN THOMPSON SCHNEIDER COOPER GRIJALVA BISHOP DANNY K. DAVIS LEVIN

biomedical clinical trials loans trials clinical guarantee clinical trial agents unmet purchase food drug secretary health drug investigational treasury shall